tiprankstipranks
pc:had5i

Hadrius

Enterprise AI
Hadrius provides agentic compliance infrastructure for financial services firms, consolidating fragmented, manual compliance workflows into a single AI-native function. The platform enables financial institutions and investment firms to run and automate comprehensive compliance programs using AI-driven tooling.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$27M
Total Amount Raised$27M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$27M
Latest Funding Amount$27M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 14, 2026
Series A
$27.00M
―

Investors

Investor Name
Funding Round
CRV
Series A
Y Combinator
Series A
Pathlight Ventures
Series A
Founders of Altruist
Series A
Founders of Jump AI
Series A
Founders of FINNY
Series A

Similar Companies

A snapshot of private companies similar to Hadrius, helping you discover and navigate related company profiles.
PC:MOTIVMotivity
PC:CLARIClarium
PC:TOM2FTomorro
PC:TRA6JTranslucent

Related News and Analysis

Hadrius Extends AI Communications Archiving with Claude Integration for Financial Firms

Hadrius Extends AI Communications Archiving with Claude Integration for Financial Firms

New updates have been reported about Hadrius. Hadrius has integrated its agentic compliance infrastructure with Claude’s Compliance API,...
1d ago
HAD5I
Hadrius Secures $27 Million to Scale AI-Native Compliance Infrastructure

Hadrius Secures $27 Million to Scale AI-Native Compliance Infrastructure

New updates have been reported about Hadrius. Hadrius has raised $27 million in combined seed and Series A...
15d ago
HAD5I
Seed Health Unveils Mechanistic Data Backing New Co-Biotic Supplement Platform

Seed Health Unveils Mechanistic Data Backing New Co-Biotic Supplement Platform

New updates have been reported about Seed Health. Seed Health has released preclinical data showing its Co-Biotic supplement...
1h ago
SEEDH
GS Microelectronics Expands Academic Reach With Low-Cost PLL IP Program Via Muse Semiconductor

GS Microelectronics Expands Academic Reach With Low-Cost PLL IP Program Via Muse Semiconductor

New updates have been reported about GS Microelectronics. GS Microelectronics US, Inc. is deepening its engagement with academic...
2h ago
GSMIC
Carta Healthcare Clinches Back-to-Back Stevie Tech Awards for Hybrid Clinical Data Platform

Carta Healthcare Clinches Back-to-Back Stevie Tech Awards for Hybrid Clinical Data Platform

New updates have been reported about Carta Healthcare. Carta Healthcare has strengthened its position in enterprise clinical data...
2h ago
CARTA
Pentera Adds AI-Native Web App Testing to Autonomous Security Validation Platform

Pentera Adds AI-Native Web App Testing to Autonomous Security Validation Platform

New updates have been reported about Pentera. Pentera has expanded its autonomous security validation platform with AI-native web...
2h ago
PENTE
Lunar Outpost Wins NASA Collaboration to Advance Starweave Autonomy Platform

Lunar Outpost Wins NASA Collaboration to Advance Starweave Autonomy Platform

New updates have been reported about Lunar Outpost. Lunar Outpost has secured a new NASA collaboration to further...
3h ago
LUNAR
Truveta Advances Oncology Data with AI Model That Extracts Cancer Staging at Scale

Truveta Advances Oncology Data with AI Model That Extracts Cancer Staging at Scale

New updates have been reported about Truveta. Truveta has released peer-reviewed evidence that its Truveta Language Model for...
3h ago
TRVTA
Citizen Health Deploys AI Advocate Ari to Angelman Syndrome Community via ASF Partnership

Citizen Health Deploys AI Advocate Ari to Angelman Syndrome Community via ASF Partnership

New updates have been reported about Citizen Health. Citizen Health has entered a strategic partnership with the Angelman...
3h ago
CITIZ
Ractigen’s RAG-17 Data in Nature Medicine Strengthens CNS RNAi Strategy for SOD1-ALS

Ractigen’s RAG-17 Data in Nature Medicine Strengthens CNS RNAi Strategy for SOD1-ALS

New updates have been reported about Ractigen Therapeutics. Ractigen Therapeutics has secured a high-profile validation of its CNS...
3h ago
RACTI